HLA-A29
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
| major histocompatibility complex (human), class I, A29
| ||
| Alleles | A*2901 A*2902 A*2903 | |
| Structure (See HLA-A) | ||
| Identifiers | 2901 2902 2903
| |
| Symbol(s) | HLA-A | |
| EBI-HLA | A*2901 | |
| EBI-HLA | A*2902 | |
| EBI-HLA | A*2903 | |
| Shared data | ||
| Locus | chr.6 6p21.31 | |
HLA-A29 (A29) is an HLA-A serotype. The serotype identifies the more common HLA-A*29 gene products. A29 is a split antigen of the A19 broad antigen serotype group. It is similar to the antigens A30, A31, A32, A33, and A74. A31 is more common in Japan, Siberia and Indigenous Americans. It is also more frequent in NE Europe than SW Europe.
Serotype
| A*29 | A29 | A19 | Sample |
| allele | % | % | size (N) |
| 2901 | 96 | 119 | |
| 2902 | 99 | 1148 | |
| 2903 | 100 | 4 |
A29 Allele frequencies
A*2902
A29-B Haplotypes
| freq | ||
| ref. | Population | (%) |
| A29-Cw16-B44(A*2902:Cw*1601:B*4403) | ||
| Basque, Gipuzkoa (Spain) | 10.3 | |
| Basque, San Sebastion (Spain) | 7.5 | |
| Pasiegos valley (Spain) | 5.4 | |
| Basque, Arratia (Spain) | 5.3 | |
| [2] | Cornish (Gr. Britain) | 5.3 |
| [2] | Spanish | 5.0 |
| Huate Corse (France) | 4.3 | |
| Paris (France) | 3.9 | |
| Portuguese | 3.5 | |
| [2] | French | 3.4 |
| Irish | 3.4 | |
| S. African (Indig.) | 2.7 | |
| N. Irish | 2.8 | |
| [2] | Dane | 2.2 |
| Tunisia | 2.0 | |
| Wales | 2.0 | |
| Tuscan | 1.7 | |
| Dutch | 1.4 | |
| German | 1.3 | |
| Rainforest (Cameroon) | 1.3 | |
A29-Cw16-B44(A*2902:Cw*1601:B*4403) appears to have originated in West Africa were Cw*16 frequency is highest and had undergone more linkage equilibrium. Cw*16 decline slowly heading north and more rapidly to the east and northeast, with the highest frequency/latitude north generally along Eastern Spain into the British Ilses, some flow up the channel but haplotype frequency drops in the interior of Europe.
This haplotype can generally be extended from A- to -DQ as A29-Cw16-B44-DR7-DQ2.2:
A*2901 : Cw*1601 : B*4403 : DRB1*0701 : DQA1*0201 : DQB1*0202
And, the Cw16 component is in strong linkage disequilibrium with the DR7-DQ2.2 component suggesting that since the haplotypes introduction into Europe there has not been adequate time for equilibration, supporting its recent introduction into Europe. This particular haplotype supports theories of migration that are more numerous than those supported by mtDNA or Y chromosomal information, many such 'smaller' migrations are evident with HLA haplotypes, suggesting a much greater complexity to human population than haploid loci make evident.
References
- ↑ derived from IMGT/HLA
- ↑ 2.0 2.1 2.2 2.3 Sasazuki, Takehiko; Tsuji, Kimiyoshi; Aizawa, Miki (1992). HLA 1991: proceedings of the eleventh International Histocompatibility Workshop and Conference, held in Yokohama, Japan, 6-13 November, 1991. Oxford [Oxfordshire]: Oxford University Press. ISBN 0-19-262390-7.
HLA-A Serotypes |
|---|
| HLA-A - A1 - A2 - A3 - A9 (A23 - A24) - A10 (A25 - A26 - A34 - A43 - A66) - A11 - A19 (A29 - A30 - A31 - A32 - A33 - A74) - A28 (A68 - A69) - A36 - A80 |
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
